PMV Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.444; its P/E ratio is -1.18; PMV Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -18.92M	$ -19.62M	$ -20.13M	$ -21.45M	$ -21.02M
EBITDA	$ -20.44M	-	$ 0.00	$ 0.00	$ -21.47M
Net Income Common Stockholders	$ -15.76M	$ -16.64M	$ -17.44M	$ -19.13M	$ -19.34M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 203.06M	$ 201.92M	$ 187.91M	$ 230.26M	$ 241.88M
Total Assets	$ 252.15M	$ 261.03M	$ 242.22M	$ 253.96M	$ 270.31M
Total Debt	$ 13.29M	$ 12.70M	$ 12.98M	$ 13.48M	$ 13.98M
Net Debt	$ -189.77M	$ -189.22M	$ -174.93M	$ -216.78M	$ -227.90M
Total Liabilities	$ 26.46M	$ 23.41M	$ 24.41M	$ 23.79M	$ 24.28M
Stockholders Equity	$ 225.69M	$ 237.61M	$ 217.81M	$ 230.17M	$ 246.03M
Cash Flow	-
Free Cash Flow	$ -12.28M	-	-	-	$ -16.96M
Operating Cash Flow	$ -12.09M	$ -15.66M	-	-	$ -15.32M
Investing Cash Flow	$ -2.59M	$ -33.64M	-	-	$ 23.22M
Financing Cash Flow	$ 288.00K	$ 33.15M	-	-	$ 548.00K

Currency in USD

PMV Pharmaceuticals Earnings and Revenue History

Income Statement >

PMV Pharmaceuticals Debt to Assets

Balance Sheet >

PMV Pharmaceuticals Cash Flow

Cash Flow >

PMV Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing